SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Cipher Mining, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business. The company was founded in 2021 and is headquartered in New York, NY.

Cipher Mining Inc

Despite a recent offering, Cipher Mining is trending as investors see a bullish signal due to its partnership with Google and expansion into high-performance computing. The community is actively discussing the potential for significant growth, especially with the zero-interest funding deal and capped call protections against dilution. Some investors believe Cipher Mining is undervalued, positioning itself as a key player in AI infrastructure rather than just Bitcoin mining.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MLTX is trending following positive Phase 2 trial data for its skin drug, sonelokimab, leading to significant price movement and high volatility. The community is actively discussing the implications of the results, potential buyout scenarios, and the company's overall valuation with some users expressing concerns over a potential offering. Bullish sentiment seems high, but bears warn against high placebo response in study 2.

JFB Construction Holdings is a commercial and residential real estate construction and development company, which engages in delivering services to commercial and residential markets. It operates through the following segments: Commercial Construction, Residential Construction, and Real Estate Development. The Commercial Construction segment includes all activities related to the construction of commercial properties. The Residential Construction segment focuses on the construction of residential properties including single-family homes and multi-family units. The Real Estate Development segment refers to the acquisition, development, and sale of real estate properties. The company was founded by Joseph F. Basille III on April 9, 2024 and is headquartered in Lantana, FL.

JFB Construction Holdings - Ordinary Shares - Class A

JFB is trending due to a recently announced private placement of approximately $44 million, leading to significant after-hours price movement. Community discussion revolves around the potential for continued momentum, the impact of the offering, and possible short squeeze opportunities. Some traders are also noting potential dilution from warrants associated with the deal.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is trending following positive phase 3 trial results for its oral Wegovy pill, showing significant weight loss, which could broaden its market appeal; the community is weighing its potential against competitor Eli Lilly. Community members are also digesting news of job cuts impacting the US obesity education team amid an increasingly competitive GLP-1 market.

Advisorshares Trust - AdvisorShares MSOS 2x Daily ETF

AdvisorShares MSOS Daily Leveraged ETF

The AdvisorShares MSOS Daily Leveraged ETF ($MSOX) is trending due to renewed speculation around potential cannabis rescheduling and safe banking, with investors actively discussing entry points and potential upside. Bullish sentiment is building as traders anticipate a sector-wide rally, while some express concerns about the ETF's performance and correlation with its underlying assets. Community members are also weighing potential political catalysts and the impact of key figures on the industry's future.

Merus NV is a clinical-stage immuno-oncology company, which engages in the discovery and development of bispecific antibody therapeutics. Its pipeline includes Biclonics for solid and hematological tumors. The company was founded by Ton Logtenberg and Hennie Hoogenboom on June 16, 2003 and is headquartered in Utrecht, the Netherlands.

Merus N.V

Recent buzz around Merus (MRUS) is driven by buyout rumors, with Genmab reportedly leading the acquisition race, exciting retail traders. The community is also discussing Barclays' initiation of an Overweight rating with a $112 price target. Some traders are highlighting the potential of Merus's pipeline and multispecific antibody platform.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

CELH is trending amid discussions around growth prospects, potential analyst upgrades, and a possible climb to new highs, with the community actively debating entry points and year-end targets. Bullish sentiment is fueled by the Pepsi distribution partnership and Alani Nu acquisition, while some express concerns about the stock's volatility and recent price action. Discussions also involve potential catalysts, technical analysis, and the beverage's increasing presence in stores.

Enanta Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery and development of small molecule drugs for the treatment of viral infections and liver diseases. It produces clinical candidates which targets respiratory syncytial virus (RSV), hepatitis B virus (HBV), and non-alcoholic steatohepatitis (NASH) diseases. The firm also conducts research in human metapneumovirus (hMPV) and SARS-CoV-2 (COVID-19). The company was founded by Peter O. Kliem Martin Karplus, James Hogle, Gerard Wagner, Peter M. Howley, and Gregory L. Verdine in 1995 and is headquartered in Watertown, MA.

Enanta Pharmaceuticals Inc

Enanta Pharmaceuticals is trending due to the upcoming presentation of topline results from its Phase 2b study of Zelicapavir for RSV in high-risk adults, sparking considerable interest and anticipation within the investment community. Community members are actively discussing potential outcomes, speculating on significant price movements based on positive results, and highlighting unusual options activity that suggests bullish sentiment. The focus remains on the potential of the drug and its impact on the company's valuation.

Progress Software Corp. engages in the provision of products that develop and deploy mission-critical business applications. Its products and solutions include Chef, Corticon, DataDirect, Developer Tools, Flowmon, Kemp LoadMaster, MarkLogic, MOVEit, OpenEdge, Semaphore, ShareFile, Sitefinity & WhatsUp Gold. The company was founded by Joseph Wright Alsop, Clyde Kessel, and Charles Arthur Ziering in 1981 and is headquartered in Burlington, MA.

Progress Software Corp.

Progress Software ($PRGS) is trending as investors anticipate upcoming earnings and analyze analyst projections of significant stock upside. The community is actively discussing unusual options activity, with some spotting bullish call flow and others noting bearish put sweeps, leading to mixed sentiment ahead of earnings. Broader discussions include the company's growth trajectory in the technology sector, particularly its AI initiatives, and how upcoming financial results could impact market sentiment.

Hang Feng Technology Innovation Co Ltd.

Hang Feng Technology Innovation Co Ltd

Hang Feng Technology Innovation Co Ltd ($FOFO) is trending due to explosive momentum and retail excitement, with some comparing it to past high-flying stocks. Community members are discussing its unusual price action and potential upside, while also questioning the company's fundamentals. The stock's significant volume and price surge have captured attention, with traders actively watching for entry points and potential continuation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

New Strong Buy Stocks for September 19th

LRN, RL, GFI, CFBK and M have been added to the Zacks Rank #1 (Strong Buy) List on September 19, 2025.

New Strong Buy Stocks for September 2nd

RSI, UDMY, NVST, DORM and CFBK have been added to the Zacks Rank #1 (Strong Buy) List on September 2, 2025.

New Strong Buy Stocks for August 13th

CFBK, JBL, ANET, RL and NGG have been added to the Zacks Rank #1 (Strong Buy) List on August 13, 2025.

Best Value Stocks to Buy for August 13th

JBL, CFBK and MSBHF made it to the Zacks Rank #1 (Strong Buy) value stocks list on August 13, 2025.

Blue Foundry Bancorp (BLFY) Reports Q2 Loss, Tops Revenue Estimates

Blue Foundry Bancorp (BLFY) delivered earnings and revenue surprises of +9.09% and +1.05%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

MVB Financial (MVBF) Q2 Earnings and Revenues Miss Estimates

MVB Financial (MVBF) delivered earnings and revenue surprises of -51.61% and -6.06%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Esquire Financial Holdings, Inc. (ESQ) Matches Q2 Earnings Estimates

Esquire Financial (ESQ) delivered earnings and revenue surprises of 0.00% and +3.69%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Hanover Bancorp, Inc. (HNVR) Misses Q2 Earnings and Revenue Estimates

Hanover Bancorp (HNVR) delivered earnings and revenue surprises of -42.11% and -3.90%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

CF BANKSHARES INC., PARENT OF CFBANK, NA, ANNOUNCES QUARTERLY CASH DIVIDEND

CF BANKSHARES INC., PARENT OF CFBANK, NA, ANNOUNCES QUARTERLY CASH DIVIDEND CF BANKSHARES INC., PARENT OF CFBANK, NA, ANNOUNCES QUARTERLY CASH DIVIDEND PR Newswire COLUMBUS, Ohio, Jan. 6, 2025...

CF BANKSHARES INC., PARENT OF CFBANK, NA, ANNOUNCES 17% INCREASE IN ITS QUARTERLY CASH DIVIDEND

CF BANKSHARES INC., PARENT OF CFBANK, NA, ANNOUNCES 17% INCREASE IN ITS QUARTERLY CASH DIVIDEND CF BANKSHARES INC., PARENT OF CFBANK, NA, ANNOUNCES 17% INCREASE IN ITS QUARTERLY CASH DIVIDEND PR...

CF Bankshares, Inc. operates as a financial holding company which is engaged in the provision of business banking products and services. Its products and services include commercial loans and leases, commercial and residential real estate loans and treasury management depository services. It operates through the Real Estate and Consumer segments. The company was founded in September 1998 and is headquartered in Columbus, OH.

CF Bankshares Inc

Will the U.S. government shut down in 2025? 
 
*Powered by Polymarket

CFBK
CF Bankshares Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest CFBK News

CFBK CF Bankshares Inc